145 related articles for article (PubMed ID: 34742454)
1. O-carboxymethyl chitosan based pH/hypoxia-responsive micelles relieve hypoxia and induce ROS in tumor microenvironment.
Jiang L; Zhang M; Bai Y; Cui F; Zhang C; Wang Z; Si S; Yang L; Wang Y; Zhang Y; Li L; Liu S; Wei X; Wang Y; Xu Y; Meng J
Carbohydr Polym; 2022 Jan; 275():118611. PubMed ID: 34742454
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-releasing micelles with intelligent targeting for enhanced anti-tumor effect of cisplatin in hypoxia.
Chen Y; Fang L; Zhou W; Chang J; Zhang X; He C; Chen C; Yan R; Yan Y; Lu Y; Xu C; Xiang G
J Nanobiotechnology; 2021 Aug; 19(1):246. PubMed ID: 34399762
[TBL] [Abstract][Full Text] [Related]
3. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional albumin-MnO₂ nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response.
Prasad P; Gordijo CR; Abbasi AZ; Maeda A; Ip A; Rauth AM; DaCosta RS; Wu XY
ACS Nano; 2014 Apr; 8(4):3202-12. PubMed ID: 24702320
[TBL] [Abstract][Full Text] [Related]
5. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
6. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
[TBL] [Abstract][Full Text] [Related]
7. Smart Responsive Quercetin-Conjugated Glycol Chitosan Prodrug Micelles for Treatment of Inflammatory Bowel Diseases.
Shen C; Zhao L; Du X; Tian J; Yuan Y; Jia M; He Y; Zeng R; Qiao R; Li C
Mol Pharm; 2021 Mar; 18(3):1419-1430. PubMed ID: 33522827
[TBL] [Abstract][Full Text] [Related]
8. Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects.
Meng L; Cheng Y; Tong X; Gan S; Ding Y; Zhang Y; Wang C; Xu L; Zhu Y; Wu J; Hu Y; Yuan A
ACS Nano; 2018 Aug; 12(8):8308-8322. PubMed ID: 30102510
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
Noman MZ; Desantis G; Janji B; Hasmim M; Karray S; Dessen P; Bronte V; Chouaib S
J Exp Med; 2014 May; 211(5):781-90. PubMed ID: 24778419
[TBL] [Abstract][Full Text] [Related]
10. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment-responsive micelles for pinpointed intracellular release of doxorubicin and enhanced anti-cancer efficiency.
Chen WL; Yang SD; Li F; Li JZ; Yuan ZQ; Zhu WJ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2016 Sep; 511(2):728-40. PubMed ID: 27484835
[TBL] [Abstract][Full Text] [Related]
13. Hepatoma-targeting and reactive oxygen species-responsive chitosan-based polymeric micelles for delivery of celastrol.
Zhang X; Xu X; Wang X; Lin Y; Zheng Y; Xu W; Liu J; Xu W
Carbohydr Polym; 2023 Mar; 303():120439. PubMed ID: 36657834
[TBL] [Abstract][Full Text] [Related]
14. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
15. The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia.
Ding XC; Wang LL; Zhang XD; Xu JL; Li PF; Liang H; Zhang XB; Xie L; Zhou ZH; Yang J; Weichselbaum RR; Yu JM; Hu M
J Hematol Oncol; 2021 Jun; 14(1):92. PubMed ID: 34118979
[TBL] [Abstract][Full Text] [Related]
16. Detection of reactive oxygen species via endogenous oxidative pentose phosphate cycle activity in response to oxygen concentration: implications for the mechanism of HIF-1alpha stabilization under moderate hypoxia.
Tuttle SW; Maity A; Oprysko PR; Kachur AV; Ayene IS; Biaglow JE; Koch CJ
J Biol Chem; 2007 Dec; 282(51):36790-6. PubMed ID: 17666400
[TBL] [Abstract][Full Text] [Related]
17.
Kim S; Sundaram A; Mathew AP; Hareshkumar VS; Mohapatra A; Thomas RG; Bui TTM; Moon K; Kweon S; Park IK; Jeong YY
Biomater Sci; 2023 Sep; 11(18):6177-6192. PubMed ID: 37504889
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression.
Tatli Dogan H; Kiran M; Bilgin B; Kiliçarslan A; Sendur MAN; Yalçin B; Ardiçoglu A; Atmaca AF; Gumuskaya B
Diagn Pathol; 2018 Aug; 13(1):60. PubMed ID: 30144808
[TBL] [Abstract][Full Text] [Related]
19. Feedback of hypoxia-inducible factor-1alpha (HIF-1alpha) transcriptional activity via redox factor-1 (Ref-1) induction by reactive oxygen species (ROS).
Kobayashi Y; Oguro A; Imaoka S
Free Radic Res; 2021 Feb; 55(2):154-164. PubMed ID: 33410354
[TBL] [Abstract][Full Text] [Related]
20. Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.
Hatfield SM; Kjaergaard J; Lukashev D; Belikoff B; Schreiber TH; Sethumadhavan S; Abbott R; Philbrook P; Thayer M; Shujia D; Rodig S; Kutok JL; Ren J; Ohta A; Podack ER; Karger B; Jackson EK; Sitkovsky M
J Mol Med (Berl); 2014 Dec; 92(12):1283-92. PubMed ID: 25120128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
